Orleans Capital Management’s Gilead Sciences GILD Stock Holding History

Orleans Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.51M	Buy	10,852 +248	+2%	+$34.7K	1.02%	37
2025 Q4	$1.3M	Buy	10,604 +3,024	+40%	+$367K	0.81%	39
2025 Q3	$841K	Sell	7,580 -965	-11%	-$110K	0.54%	52
2025 Q2	$947K	Buy	+8,545	New	+$909K	0.5%	54
2018 Q3	–	Sell	-12,073	Closed	-$855K	–	83
2018 Q2	$855K	Sell	12,073 -240	-2%	-$16.9K	0.62%	54
2018 Q1	$928K	Buy	12,313 +386	+3%	+$30.7K	0.68%	50
2017 Q4	$854K	Sell	11,927 -5,090	-30%	-$387K	0.61%	55
2017 Q3	$1.38M	Buy	17,017 +6,588	+63%	+$504K	1.03%	40
2017 Q2	$738K	Sell	10,429 -75	-0.7%	-$4.99K	0.52%	57
2017 Q1	$713K	Hold	10,504	–	–	0.5%	59
2016 Q4	$752K	Sell	10,504 -5,595	-35%	-$416K	0.54%	59
2016 Q3	$1.27M	Buy	16,099 +625	+4%	+$50.8K	0.88%	50
2016 Q2	$1.29M	Buy	15,474 +2,060	+15%	+$183K	0.9%	51
2016 Q1	$1.23M	Buy	13,414 +195	+1%	+$17.6K	0.93%	51
2015 Q4	$1.34M	Buy	13,219 +7,253	+122%	+$755K	1.03%	43
2015 Q3	$586K	Buy	+5,966	New	+$663K	0.47%	64

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Orleans Capital Management's GILD Position: Q1 2026 in Review

Orleans Capital Management increased its Gilead Sciences (GILD) stake by 2.3% in Q1 2026, buying an estimated $34.7K and bringing the position to 10,852 shares worth $1.51M. The position accounts for 1.02% of the portfolio, ranked #37.

Orleans Capital Management first reported a position in GILD in Q3 2015 and has held it in 16 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Orleans Capital Management held 10,852 shares of Gilead Sciences worth $1.51M as of Q1 2026.
Orleans Capital Management bought 248 Gilead Sciences shares in Q1 2026, an estimated $34.7K.
Gilead Sciences made up 1.02% of Orleans Capital Management's portfolio in Q1 2026, its #37 holding.
Orleans Capital Management first reported a position in Gilead Sciences in Q3 2015 and has held it in 16 quarters since.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Orleans Capital Management's 13F filing for Q1 2026, filed 14 May 2026.